Gibson, G. E., Flowers, S. A., Feldman, H. H., Luchsinger, J. A., & Zhang, S. (2024). Pharmacological thiamine (Vitamin B1) as a treatment for alzheimer’s disease. Alzheimer’s & Dementia, 20(S6). Portico. https://doi.org/10.1002/alz.086468

Feldman, H. H., Luchsinger, J. A., Léger, G. C., Taylor, C., Jacobs, D. M., Salmon, D. P., Edland, S. D., Messer, K., Revta, C., Flowers, S. A., Jones, K. S., Koulman, A., Yarasheski, K. E., Verghese, P. B., Venkatesh, V., Zetterberg, H., Durant, J., Lupo, J.-L., & Gibson, G. E. (2024). Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer’s disease (BenfoTeam). PLOS ONE, 19(5), e0302998. https://doi.org/10.1371/journal.pone.0302998

Gibson, G. E., Feldman, H. H., Zhang, S., Flowers, S. A., & Luchsinger, J. A. (2022). Pharmacological thiamine levels as a therapeutic approach in Alzheimer’s disease. Frontiers in Medicine, 9. https://doi.org/10.3389/fmed.2022.1033272